FDA recall D-0016-2017

Leiter's Compounding · Class II · drug

Product

Moxifloxacin 1 mg/mL in Sterile Balanced Salt Solution (BSS) Intravitreal Injection, 1 mL Total Volume in a 2 mL Vial, Compounded by Leiter's Compounding, San Jose, CA --- NDC 70360-003-35

Reason for recall

Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2016-09-20
Report date
2016-10-19
Termination date
2017-05-03
Voluntary/Mandated
Voluntary: Firm initiated
Location
San Jose, CA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0016-2017